SCD1 Regulates Osteoclast Differentiation by Modulating Arachidonic Acid Metabolism and Mitochondrial Homeostasis
The FASEB Journal · 31.05.2026 · 40 (10)
DOI: 10.1096/fj.202600672r ↗Kurz gefasst
Fachartikel in der Zeitschrift The FASEB Journal, online erschienen am 13.05.2026. Verfasst von Yihao Zhao und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedic Surgery, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China. Hauptthemen laut MEDLINE: Stearoyl-CoA Desaturase, Arachidonic Acids, Osteoclasts, Bone Resorption. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: MOST | National Natural Science Foundation of China (NSFC), Zhejiang Provincial Natural Science Foundation of China, MOST | | Medical Science and Technology Project of Zhejiang Province ().
Abstract (Originalsprache)
Bone homeostasis is maintained by a dynamic balance between bone formation and resorption. Here, we link lipid metabolism to osteoclast differentiation by identifying stearoyl‐CoA desaturase‐1 (SCD1) as a key regulatory factor. Notably, SCD1 expression was significantly upregulated during osteoclast differentiation, and knockdown of SCD1 or inhibiting its activity with A939572 significantly impaired osteoclast formation. Integrating RNA sequencing and metabolomics, we revealed that SCD1 inhibition altered arachidonic acid metabolism and influenced mitochondrial homeostasis. Mechanistically, A939572 upregulated COX1 and HPGDS expression, leading to the accumulation of Prostaglandin D2 (PGD2), which in turn suppressed osteoclast differentiation. Finally, we engineered a biomimetic nanovesicle (POCM‐NP@A939572) coated with preosteoclast membrane for targeted delivery. In vivo, POCM‐NP@A939572 exhibited superior efficacy in preventing bone loss compared to A939572 alone. Collectively, this study demonstrates the SCD1‐COX1‐PGD2 axis as a therapeutic target and demonstrates the value of targeted nanomedicine in managing bone diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Orthopaedic Surgery, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China.
- Zhejiang Key Laboratory of Mechanism Research and Precision Repair of Orthopaedic Trauma and Aging Diseases, Hangzhou, China.
- Department of Orthopedics, Ningbo No. 2 Hospital, Ningbo, China.
- School of Medicine, Hangzhou City University, Hangzhou, China.
- Department of Wound Healing, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Förderung
- MOST | National Natural Science Foundation of China (NSFC)
- Zhejiang Provincial Natural Science Foundation of China
- MOST | | Medical Science and Technology Project of Zhejiang Province ()
- National Natural Science Foundation of China
- Natural Science Foundation of Zhejiang Province
- Medical Science and Technology Project of Zhejiang Province
Zitieren
APA
Zhao, Y., Wei, X., Wu, H., Yao, C., Zheng, Z., Chen, W., Feng, Z., Huang, B., Cai, Z., Xue, Q., Chen, J., Zhao, F., & Liu, J. (2026). SCD1 Regulates Osteoclast Differentiation by Modulating Arachidonic Acid Metabolism and Mitochondrial Homeostasis. The FASEB Journal, 40(10). https://doi.org/10.1096/fj.202600672r
Vancouver
Zhao Y, Wei X, Wu H, Yao C, Zheng Z, Chen W, et al. SCD1 Regulates Osteoclast Differentiation by Modulating Arachidonic Acid Metabolism and Mitochondrial Homeostasis. The FASEB Journal. 2026;40(10). doi:10.1096/fj.202600672r
BibTeX
@article{Zhao2026,
author = {Zhao, Yihao and Wei, Xiaoan and Wu, Haihao and Yao, Chengjun and Zheng, Zeyu and Chen, Weishao and Feng, Zhenhua and Huang, Bao and Cai, Zimin and Xue, Qize and Chen, Jian and Zhao, Fengdong and Liu, Junhui},
title = {SCD1 Regulates Osteoclast Differentiation by Modulating Arachidonic Acid Metabolism and Mitochondrial Homeostasis},
journal = {The FASEB Journal},
year = {2026},
volume = {40},
number = {10},
doi = {10.1096/fj.202600672r}
}
EUVIMED